Pridopidine for treating Huntington's disease [ID6525]

  • In development
  • GID-TA11637
  • Expected publication date: TBC

Suggested remit: To appraise the clinical and cost effectiveness of Polihexanide (Akantior) eye drops within its marketing authorisation for treating acanthamoeba keratitis in people 12 years and over

Documents